ZA885095B - Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles - Google Patents
Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cyclesInfo
- Publication number
- ZA885095B ZA885095B ZA885095A ZA885095A ZA885095B ZA 885095 B ZA885095 B ZA 885095B ZA 885095 A ZA885095 A ZA 885095A ZA 885095 A ZA885095 A ZA 885095A ZA 885095 B ZA885095 B ZA 885095B
- Authority
- ZA
- South Africa
- Prior art keywords
- double
- tumor cell
- stranded rna
- metabolic pathways
- virus growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7464987A | 1987-07-17 | 1987-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA885095B true ZA885095B (en) | 1989-07-26 |
Family
ID=22120800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA885095A ZA885095B (en) | 1987-07-17 | 1988-07-14 | Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP0299745B1 (no) |
| JP (1) | JPH01104015A (no) |
| KR (1) | KR970007903B1 (no) |
| CN (1) | CN1032741A (no) |
| AT (1) | ATE123222T1 (no) |
| AU (3) | AU1820388A (no) |
| CA (1) | CA1331345C (no) |
| DE (1) | DE3853898T2 (no) |
| DK (1) | DK363088A (no) |
| ES (1) | ES2075835T3 (no) |
| FI (1) | FI883351A (no) |
| GR (1) | GR3017271T3 (no) |
| IE (1) | IE75896B1 (no) |
| IL (1) | IL86865A (no) |
| NO (1) | NO882854L (no) |
| PT (1) | PT87997B (no) |
| RU (1) | RU1838419C (no) |
| ZA (1) | ZA885095B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE72103B1 (en) * | 1987-08-12 | 1997-03-12 | Hem Res Inc | Promotion of host defense by systemic dsRNA treatment |
| ATE122402T1 (de) * | 1987-09-04 | 1995-05-15 | Hem Pharma Corp | Diagnose von mangelzuständen doppelsträngiger rns. |
| NO883868L (no) * | 1987-09-04 | 1989-03-06 | Hem Res Inc | Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander. |
| US4963532A (en) * | 1987-11-25 | 1990-10-16 | Hem Research, Inc. | dsRNA-based prevention of viral escape |
| DE68914201T2 (de) * | 1988-07-07 | 1994-07-14 | Hem Pharma Corp | Diagnose und Behandlung chronischer Ermüdungserscheinungen. |
| ZA908037B (en) * | 1989-10-11 | 1991-09-25 | Hem Res Inc | Protection from shock subsequent to injury by double-standed rnas |
| AU6740590A (en) * | 1989-10-11 | 1991-05-16 | Hem Research, Inc. | Protection from shock subsequent to injury by double-stranded rnas |
| GB9108085D0 (en) * | 1991-04-16 | 1991-06-05 | Scras | Complexes of polyadenylic acid with polyuridylic acid |
| CA2113573A1 (en) * | 1991-07-16 | 1993-02-04 | William Carter | Modulation and diagnosis of cytokine dysfunctions |
| US5985565A (en) * | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| TW524693B (en) * | 1997-10-16 | 2003-03-21 | Nippon Shinyaku Co Ltd | Cancer cell nuclease activator |
| US6207366B1 (en) | 1999-04-14 | 2001-03-27 | Temple University- Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| CN100358534C (zh) * | 2005-11-21 | 2008-01-02 | 北京百林康源生物技术有限责任公司 | 错位双链寡核苷酸在制备治疗禽流感病毒感染的药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024222A (en) | 1973-10-30 | 1977-05-17 | The Johns Hopkins University | Nucleic acid complexes |
| DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
| CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
-
1988
- 1988-06-21 AU AU18203/88A patent/AU1820388A/en not_active Abandoned
- 1988-06-22 IE IE189588A patent/IE75896B1/en not_active IP Right Cessation
- 1988-06-26 IL IL86865A patent/IL86865A/xx not_active IP Right Cessation
- 1988-06-28 NO NO88882854A patent/NO882854L/no unknown
- 1988-06-30 DK DK363088A patent/DK363088A/da not_active Application Discontinuation
- 1988-07-13 EP EP88306419A patent/EP0299745B1/en not_active Expired - Lifetime
- 1988-07-13 DE DE3853898T patent/DE3853898T2/de not_active Expired - Fee Related
- 1988-07-13 ES ES88306419T patent/ES2075835T3/es not_active Expired - Lifetime
- 1988-07-13 EP EP19920203073 patent/EP0525917A3/en not_active Withdrawn
- 1988-07-13 AT AT88306419T patent/ATE123222T1/de not_active IP Right Cessation
- 1988-07-14 ZA ZA885095A patent/ZA885095B/xx unknown
- 1988-07-14 FI FI883351A patent/FI883351A/fi not_active Application Discontinuation
- 1988-07-15 PT PT87997A patent/PT87997B/pt not_active IP Right Cessation
- 1988-07-15 JP JP63175313A patent/JPH01104015A/ja active Pending
- 1988-07-15 RU SU884356183A patent/RU1838419C/ru active
- 1988-07-15 CA CA000572123A patent/CA1331345C/en not_active Expired - Fee Related
- 1988-07-16 KR KR1019880008902A patent/KR970007903B1/ko not_active IP Right Cessation
- 1988-07-16 CN CN88106117A patent/CN1032741A/zh active Pending
-
1992
- 1992-05-12 AU AU16190/92A patent/AU1619092A/en not_active Abandoned
-
1995
- 1995-03-23 AU AU15026/95A patent/AU1502695A/en not_active Abandoned
- 1995-08-31 GR GR950402373T patent/GR3017271T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL86865A (en) | 1993-06-10 |
| EP0525917A3 (en) | 1993-02-24 |
| PT87997B (pt) | 1995-03-01 |
| IE881895L (en) | 1989-01-17 |
| PT87997A (pt) | 1989-06-30 |
| AU1820388A (en) | 1989-01-19 |
| RU1838419C (ru) | 1993-08-30 |
| DK363088A (da) | 1989-01-18 |
| DE3853898D1 (de) | 1995-07-06 |
| FI883351A (fi) | 1989-01-18 |
| DK363088D0 (da) | 1988-06-30 |
| CA1331345C (en) | 1994-08-09 |
| KR970007903B1 (ko) | 1997-05-17 |
| KR890002420A (ko) | 1989-04-10 |
| FI883351A0 (fi) | 1988-07-14 |
| EP0299745A3 (en) | 1989-12-06 |
| ATE123222T1 (de) | 1995-06-15 |
| ES2075835T3 (es) | 1995-10-16 |
| IE75896B1 (en) | 1997-09-24 |
| NO882854D0 (no) | 1988-06-28 |
| EP0299745A2 (en) | 1989-01-18 |
| EP0299745B1 (en) | 1995-05-31 |
| JPH01104015A (ja) | 1989-04-21 |
| GR3017271T3 (en) | 1995-11-30 |
| CN1032741A (zh) | 1989-05-10 |
| IL86865A0 (en) | 1988-11-30 |
| NO882854L (no) | 1989-01-18 |
| EP0525917A2 (en) | 1993-02-03 |
| AU1502695A (en) | 1995-07-06 |
| DE3853898T2 (de) | 1996-02-29 |
| AU1619092A (en) | 1992-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Althaus et al. | Effects of altered [ADP-ribose] n metabolism on expression of fetal functions by adult hepatocytes | |
| EP0299745A3 (en) | Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles | |
| EP0288163A3 (en) | Oligodeoxynucleotides as inhibitors of the replication of retroviruses and the expression of oncogenes | |
| EP0285950A3 (en) | A drug delivery conjugate | |
| EP0341904A3 (en) | Method for predicting the effectiveness of antineoplastic therapy in individual patients | |
| WO2002061033A3 (en) | Transfection of human embryonic stem cells | |
| HK1047129A1 (en) | Sequence-specific dna recombination in eukaryotic cells | |
| MX9801264A (es) | Control de la expresion del gen de cd44 para uso terapeutico. | |
| NO179953C (no) | Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode | |
| WO1999015643A3 (en) | ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE | |
| IL95875A0 (en) | Illudin analogs,pharmaceutical compositions containing the same and methods for the use thereof | |
| ES8707565A1 (es) | Un procedimiento para producir un anticuerpo monoclonal | |
| IL85205A0 (en) | Plasmid capable of high level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity | |
| EP0061277A3 (en) | Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells | |
| ES8304801A1 (es) | Un metodo para preparar una vacuna contra vibrio anguillarum | |
| WO1993013204A3 (de) | Mittel zur stimulierung der teilungsaktivität tierischer zellen | |
| WO1999045116A3 (en) | Human homolog of a nuclear migration gene and its use | |
| Starostina et al. | Prediction of microbial resistance to polyacrylamide gel immobilization. | |
| JPS53127888A (en) | Preparation of glycerol-dehydrogenase | |
| IE780730L (en) | Veterinary composition | |
| JPS5639795A (en) | Preparation of interferon | |
| IL62927A0 (en) | Microinjection of rna and dna into living cells with the acid of reconstituted virus envelopes | |
| ZA88554B (en) | High level expression in e.coli of soluble mature hil-1beta and derivatives with altered biological activity |